CUSIP: 19243A104
Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,713,527
-
Share change
-
-36,606
-
Total reported value
-
$13,418,000
-
Price per share
-
$1.74
-
Number of holders
-
32
-
Value change
-
-$71,045
-
Number of buys
-
8
-
Number of sells
-
22
Quarterly Holders Quick Answers
What is CUSIP 19243A104?
CUSIP 19243A104 identifies CGNT - COGENTIX MED INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2017
-
Previous quarter:
Q1 2017
Recent filing periods for CUSIP 19243A104:
Institutional Holders of COGENTIX MED INC - COM (CGNT) as of Q2 2017
As of 30 Jun 2017,
COGENTIX MED INC - COM (CGNT) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,713,527 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, Broadfin Capital, LLC, PERKINS CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, DAFNA Capital Management LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BARD ASSOCIATES INC, Manatuck Hill Partners, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.